This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hof, H.
Right arrow Articles by Kretschmar, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hof, H.
Right arrow Articles by Kretschmar, M.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, 04 1997, 345-357, Vol 10, No. 2
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Management of listeriosis

H Hof, T Nichterlein and M Kretschmar
Institute of Medical Microbiology and Hygiene, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Germany.

Determination of the MIC in vitro is often used as the basis for predicting the clinical efficacy of antibiotics. Listeriae are uniformly susceptible in vitro to most common antibiotics except cephalosporins and fosfomycin. However, the clinical outcome is poor. This is partially because listeriae are refractory to the bactericidal mechanisms of many antibiotics, especially to ampicillin-amoxicillin, which still is regarded as the drug of choice. A true synergism can be achieved by adding gentamicin. Another point is that listeriae are able to reside and multiply within host cells, e.g., macrophages, hepatocytes, and neurons, where they are protected from antibiotics in the extracellular fluid. Only a few agents penetrate, accumulate, and reach the cytosol of host cells, where the listeriae are found. Furthermore, certain host cells may exclude antibiotics from any intracellular compartment. Thus, determination of the antibacterial efficacy of a drug against listeriae in cell cultures may be a better approximation of potential therapeutic value. Certain host cells may have acquired the property of excluding certain antibiotics, for example macrolides, from intracellular spaces, which might explain therapeutic failures of antibiotic therapy in spite of low MICs. Animal models do not completely imitate human listeriosis, which is characterized by meningitis, encephalitis, soft tissue and parenchymal infections, and bacteremia. Meningitis produced in rabbits is a hyperacute disease, whereby most listeriae lie extracellularly, fairly accessible to antibiotics that can cross the blood-cerebrospinal fluid barrier. In the murine model of systemic infection, Listeria monocytogenes is located mainly within macrophages and parenchymal cells of the spleen and liver, hardly accessible to certain drugs, such as ampicillin and gentimicin. The therapeutic efficacy of drugs clearly depends on the model used. Thus, for example, the combination of ampicillin with gentamicin acts synergistically in the rabbit meningitis model but not in the mouse model. Since conventional antimicrobial therapy with antibiotics is not satisfactory, particularly in the immunocompromised host (about 30% of patients with listeriosis die in spite of a rational choice of antibiotics), other possibilities must be considered for therapy as well as prevention. Indeed, listeriae are highly susceptible to several endogenous antibiotics, such as defensins. Bacteriocins produced by related bacterial species, e.g., lactobacilli and enterococci, are rapidly bactericidal. However, unfortunately, the use of such alternative measures along with immunization and immunmodulation is not yet feasible.


This article has been cited by other articles:

  • Mitja, O., Pigrau, C., Ruiz, I., Vidal, X., Almirante, B., Planes, A.-M., Molina, I., Rodriguez, D., Pahissa, A. (2009). Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study. J Antimicrob Chemother 64: 416-423 [Abstract] [Full Text]  
  • Grayo, S., Lott-Desroches, M.-C., Dussurget, O., Respaud, R., Fontanet, A., Join-Lambert, O., Singlas, E., Le Monnier, A. (2008). Rapid Eradication of Listeria monocytogenes by Moxifloxacin in a Murine Model of Central Nervous System Listeriosis. Antimicrob. Agents Chemother. 52: 3210-3215 [Abstract] [Full Text]  
  • Grayo, S., Join-Lambert, O., Desroches, M. C., Le Monnier, A. (2008). Comparison of the In Vitro Efficacies of Moxifloxacin and Amoxicillin against Listeria monocytogenes. Antimicrob. Agents Chemother. 52: 1697-1702 [Abstract] [Full Text]  
  • Sipahi, O. R., Turhan, T., Pullukcu, H., Calik, S., Tasbakan, M., Sipahi, H., Arda, B., Yamazhan, T., Ulusoy, S. (2008). Moxifloxacin versus ampicillin + gentamicin in the therapy of experimental Listeria monocytogenes meningitis. J Antimicrob Chemother 61: 670-673 [Abstract] [Full Text]  
  • Deckert, M., Virna, S., Sakowicz-Burkiewicz, M., Lutjen, S., Soltek, S., Bluethmann, H., Schluter, D. (2007). Interleukin-1 Receptor Type 1 Is Essential for Control of Cerebral but Not Systemic Listeriosis. Am. J. Pathol. 170: 990-1002 [Abstract] [Full Text]  
  • Virna, S., Deckert, M., Lutjen, S., Soltek, S., Foulds, K. E., Shen, H., Korner, H., Sedgwick, J. D., Schluter, D. (2006). TNF Is Important for Pathogen Control and Limits Brain Damage in Murine Cerebral Listeriosis. J. Immunol. 177: 3972-3982 [Abstract] [Full Text]  
  • Begley, M., Hill, C., Ross, R. P. (2006). Tolerance of Listeria monocytogenes to Cell Envelope-Acting Antimicrobial Agents Is Dependent on SigB.. Appl. Environ. Microbiol. 72: 2231-2234 [Abstract] [Full Text]  
  • Bertrand, S., Huys, G., Yde, M., D'Haene, K., Tardy, F., Vrints, M., Swings, J., Collard, J.-M. (2005). Detection and characterization of tet(M) in tetracycline-resistant Listeria strains from human and food-processing origins in Belgium and France. J Med Microbiol 54: 1151-1156 [Abstract] [Full Text]  
  • Popescu, G A, Saquepee, M, Poisson, D, Prazuck, T (2004). Treatment difficulties of a listerial rhombencephalitis in an adult patient allergic to penicillins. J. Clin. Pathol. 57: 665-666 [Abstract] [Full Text]  
  • Drevets, D. A., Leenen, P. J. M., Greenfield, R. A. (2004). Invasion of the Central Nervous System by Intracellular Bacteria. Clin. Microbiol. Rev. 17: 323-347 [Abstract] [Full Text]  
  • Krut, O., Sommer, H., Kronke, M. (2004). Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells. J Antimicrob Chemother 53: 167-173 [Abstract] [Full Text]  
  • Kallipolitis, B. H., Ingmer, H., Gahan, C. G., Hill, C., Sogaard-Andersen, L. (2003). CesRK, a Two-Component Signal Transduction System in Listeria monocytogenes, Responds to the Presence of Cell Wall-Acting Antibiotics and Affects {beta}-Lactam Resistance. Antimicrob. Agents Chemother. 47: 3421-3429 [Abstract] [Full Text]  
  • Chanteux, H., Mingeot-Leclercq, M.-P., Sonveaux, E., Van Bambeke, F., Tulkens, P. M. (2003). Intracellular accumulation and activity of ampicillin used as free drug and as its phthalimidomethyl or pivaloyloxymethyl ester (pivampicillin) against Listeria monocytogenes in J774 macrophages. J Antimicrob Chemother 52: 610-615 [Abstract] [Full Text]  
  • Godreuil, S., Galimand, M., Gerbaud, G., Jacquet, C., Courvalin, P. (2003). Efflux Pump Lde Is Associated with Fluoroquinolone Resistance in Listeria monocytogenes. Antimicrob. Agents Chemother. 47: 704-708 [Abstract] [Full Text]  
  • Safdar, A., Armstrong, D. (2003). Antimicrobial Activities against 84 Listeria monocytogenes Isolates from Patients with Systemic Listeriosis at a Comprehensive Cancer Center (1955-1997). J. Clin. Microbiol. 41: 483-485 [Abstract] [Full Text]  
  • Cotter, P. D., Guinane, C. M., Hill, C. (2002). The LisRK Signal Transduction System Determines the Sensitivity of Listeria monocytogenes to Nisin and Cephalosporins. Antimicrob. Agents Chemother. 46: 2784-2790 [Abstract] [Full Text]  
  • Lampidis, R., Kostrewa, D., Hof, H. (2002). Molecular characterization of the genes encoding DNA gyrase and topoisomerase IV of Listeria monocytogenes. J Antimicrob Chemother 49: 917-924 [Abstract] [Full Text]  
  • Maurin, M., Raoult, D. (2001). Use of Aminoglycosides in Treatment of Infections Due to Intracellular Bacteria. Antimicrob. Agents Chemother. 45: 2977-2986 [Full Text]  
  • Vazquez-Boland, J. A., Kuhn, M., Berche, P., Chakraborty, T., Dominguez-Bernal, G., Goebel, W., Gonzalez-Zorn, B., Wehland, J., Kreft, J. (2001). Listeria Pathogenesis and Molecular Virulence Determinants. Clin. Microbiol. Rev. 14: 584-640 [Abstract] [Full Text]  
  • Remer, K. A., Jungi, T. W., Fatzer, R., Tauber, M. G., Leib, S. L. (2001). Nitric Oxide Is Protective in Listeric Meningoencephalitis of Rats. Infect. Immun. 69: 4086-4093 [Abstract] [Full Text]  
  • Drevets, D. A., Jelinek, T. A., Freitag, N. E. (2001). Listeria monocytogenes-Infected Phagocytes Can Initiate Central Nervous System Infection in Mice. Infect. Immun. 69: 1344-1350 [Abstract] [Full Text]  
  • Charpentier, E., Courvalin, P. (1999). Antibiotic Resistance in Listeria spp.. Antimicrob. Agents Chemother. 43: 2103-2108 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»